Marc D. Breton

11.0k total citations · 5 hit papers
186 papers, 6.6k citations indexed

About

Marc D. Breton is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Marc D. Breton has authored 186 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 173 papers in Endocrinology, Diabetes and Metabolism, 131 papers in Surgery and 108 papers in Genetics. Recurrent topics in Marc D. Breton's work include Diabetes Management and Research (171 papers), Pancreatic function and diabetes (130 papers) and Diabetes and associated disorders (108 papers). Marc D. Breton is often cited by papers focused on Diabetes Management and Research (171 papers), Pancreatic function and diabetes (130 papers) and Diabetes and associated disorders (108 papers). Marc D. Breton collaborates with scholars based in United States, Italy and France. Marc D. Breton's co-authors include Boris Kovatchev, Claudio Cobelli, Chiara Dalla Man, Stephen D. Patek, Dayu Lv, Stacey M. Anderson, William L. Clarke, Francesco Micheletto, Daniel R. Cherñavvsky and Mark D. DeBoer and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Marc D. Breton

178 papers receiving 6.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes

2009 591 citations Boris Kovatchev, Marc D. Breton et al. Journal of Diabetes Science and Technology profile →
The UVA/PADOVA Type 1 Diabetes Simulator

2014 554 citations Dayu Lv, Marc D. Breton et al. Journal of Diabetes Science and Technology profile →
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes

2020 284 citations Marc D. Breton, Lauren Kanapka et al. profile →
One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology

2021 165 citations Marc D. Breton, Boris Kovatchev Diabetes Technology & Therapeutics profile →
Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes

2023 81 citations R. Paul Wadwa, Bruce A. Buckingham et al. profile →

Peers

Countries citing papers authored by Marc D. Breton

Since Specialization

Citations

This map shows the geographic impact of Marc D. Breton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc D. Breton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc D. Breton more than expected).

Fields of papers citing papers by Marc D. Breton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc D. Breton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc D. Breton. The network helps show where Marc D. Breton may publish in the future.

Co-authorship network of co-authors of Marc D. Breton

This figure shows the co-authorship network connecting the top 25 collaborators of Marc D. Breton. A scholar is included among the top collaborators of Marc D. Breton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc D. Breton. Marc D. Breton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human factors in the use and efficacy of decision support technologies for type 1 diabetes: evidence from a randomized controlled trial 2025 ·Diabetes Research and Clinical Practice ·(unknown), Ralf Nass, Chiara Fabris, Anas El Fathi, Emma Emory, (unknown), (unknown), Mary C. Oliveri, (unknown), Christopher R. Barnett, Katharine Barnard‐Kelly, Linda Gonder‐Frederick, Marc D. Breton	0
2	Evolution of the Artificial Pancreas: Components and Integration—CGMs, Insulin, and AP Systems 2025 ·Journal of Diabetes Science and Technology ·Richard M. Bergenstal, Adam Heller, Marc D. Breton, Robert A. Vigersky, Susan A. Brown, Gregory P. Forlenza, Jennifer L. Sherr, Roman Hovorka, Steven J. Russell, Edward R. Damiano, Melissa S. Putman, Roy W. Beck, Éric Renard, Rayhan Lal, Claudio Cobelli, Eyal Dassau, Halis Kaan Aktürk, Michael A. Weiss, Jay S. Skyler	1
3	Registration and Real-Life Studies on Automated Insulin Delivery Systems 2025 ·Journal of Diabetes Science and Technology ·Halis Kaan Aktürk, Sue A. Brown, Roy W. Beck, Jennifer L. Sherr, Richard M. Bergenstal, Boris Kovatchev, Robert A. Vigersky, Marc D. Breton, Roman Hovorka, David C. Klonoff, (unknown)	3
4	The Virtual DCCT: Adding Continuous Glucose Monitoring to a Landmark Clinical Trial for Prediction of Microvascular Complications 2025 ·Diabetes Technology & Therapeutics ·Boris Kovatchev, (unknown), Chiara Fabris, (unknown), Anas El Fathi, Marc D. Breton, Lauren Kanapka, Craig Kollman, Tadej Battelino, Roy W. Beck	8
5	Attention Networks for Personalized Mealtime Insulin Dosing in People with Type 1 Diabetes 2024 ·IFAC-PapersOnLine ·Anas El Fathi, (unknown), Marc D. Breton	3
6	Analysis on the Practical Identifiability of the Subcutaneous Oral Glucose Minimal Model 2024 ·IFAC-PapersOnLine ·(unknown), (unknown), Marc D. Breton	0
7	Validation of the UVA Simulation Replay Methodology Using Clinical Data: Reproducing a Randomized Clinical Trial 2024 ·Diabetes Technology & Therapeutics ·(unknown), Patricio Colmegna, Marc D. Breton	2
8	Assessment of Meal Anticipation for Improving Fully Automated Insulin Delivery in Adults With Type 1 Diabetes 2023 ·Diabetes Care ·José Garcia‐Tirado, Patricio Colmegna, (unknown), (unknown), (unknown), (unknown), Charlotte L. Barnett, Mary C. Oliveri, (unknown), Sue A. Brown, Mark D. DeBoer, Marc D. Breton	19
9	Smartwatch gesture‐based meal reminders improve glycaemic control 2022 ·Diabetes Obesity and Metabolism ·(unknown), Liana Hsu, Sue A. Brown, Laura Kollar, Katelijn Vleugels, Bruce A. Buckingham, Marc D. Breton, Rayhan Lal	20
10	Insulin Replacement Across the Menstrual Cycle in Women with Type 1 Diabetes: An In Silico Assessment of the Need for Ad Hoc Technology 2022 ·Diabetes Technology & Therapeutics ·(unknown), Chiara Fabris, Marc D. Breton, Eda Cengiz	10
11	Advanced Closed-Loop Control System Improves Postprandial Glycemic Control Compared With a Hybrid Closed-Loop System Following Unannounced Meal 2021 ·Diabetes Care ·José Garcia‐Tirado, (unknown), (unknown), (unknown), (unknown), (unknown), Christian Wakeman, Charlotte L. Barnett, Mary C. Oliveri, (unknown), (unknown), Marc D. Breton, Mark D. DeBoer	33
12	An Intolerable Burden: Suicide, Intended Self-Injury and Diabetes 2020 ·Canadian Journal of Diabetes ·Katharine Barnard‐Kelly, Diana Naranjo, Shideh Majidi, Halis Kaan Aktürk, Marc D. Breton, Philippe Courtet, Émilie Olié, Rayhan Lal, Nicole L. Johnson, Mark A. Atkinson, Éric Renard	5
13	Impact of Daily Physical Activity as Measured by Commonly Available Wearables on Mealtime Glucose Control in Type 1 Diabetes 2020 ·Diabetes Technology & Therapeutics ·(unknown), Stephen D. Patek, Marc D. Breton	18
14	Multi-Hour Blood Glucose Prediction in Type 1 Diabetes: A Patient-Specific Approach Using Shallow Neural Network Models 2020 ·Diabetes Technology & Therapeutics ·(unknown), Marc D. Breton, Sriram Sankaranarayanan	25
15	Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers 2020 ·Diabetes Technology & Therapeutics ·Laya Ekhlaspour, Melissa J. Schoelwer, Gregory P. Forlenza, Mark D. DeBoer, Lisa Norlander, Liana Hsu, Ryan Kingman, (unknown), Cari Berget, Emma Emory, Bruce A. Buckingham, Marc D. Breton, R. Paul Wadwa	35
16	Closed loop control in adolescents and children during winter sports: Use of the Tandem Control‐IQ AP system 2019 ·Pediatric Diabetes ·Laya Ekhlaspour, Gregory P. Forlenza, Daniel R. Cherñavvsky, David M. Maahs, R. Paul Wadwa, Mark D. DeBoer, Laurel H. Messer, Marissa Town, (unknown), (unknown), Boris Kovatchev, Bruce A. Buckingham, Marc D. Breton	52
17	Black-box Model Identification of Physical Activity in Type-l Diabetes Patients 2018 ·PubMed ·(unknown), (unknown), José Garcia‐Tirado, Marc D. Breton, Simone Del Favero	8
18	Multinight “Bedside” Closed-Loop Control for Patients with Type 1 Diabetes 2015 ·Diabetes Technology & Therapeutics ·Sue A. Brown, Boris Kovatchev, Marc D. Breton, Stacey M. Anderson, Patrick Keith-Hynes, Stephen D. Patek, Boyi Jiang, (unknown), (unknown), Daniela Bruttomesso, Angelo Avogaro, Simone Del Favero, Federico Boscari, Silvia Galasso, R. Visentin, (unknown), Claudio Cobelli	39
19	Pharmacokinetics Modeling of Exogenous Glucagon in Type 1 Diabetes Mellitus Patients 2013 ·Diabetes Technology & Therapeutics ·Dayu Lv, Marc D. Breton, Leon S. Farhy	13
20	A tool for systematically comparing the power of tests for normality 2008 ·Journal of Statistical Computation and Simulation ·Marc D. Breton, Michael D. DeVore, Donald E. Brown	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact